Search research articles
Contact Us
Filters
Showing results (31-40 of 62) with videos related to
Page
of 7
Sort By:
Archives Des Maladies Du Coeur Et Des Vaisseaux
|
September 16, 1999
[Reduction of the pressor effect of fluoxetine after V1A-vasopressin receptor blockade in the conscious rats]
E Lazartigues, S Costes, C Brefel-Courbon, et al.
Acta Neurologica Scandinavica
|
August 24, 2017
Cognitive complaint in early Parkinson's disease: A pilot study
J Dupouy, F Ory-Magne, C Mekies, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
May 17, 2007
Levodopa raises objective pain threshold in Parkinson's disease: a RIII reflex study
A Gerdelat-Mas, M Simonetta-Moreau, C Thalamas, et al.
Clinical Neuropharmacology
|
October 6, 2000
A pharmacoeconomic evaluation of botulinum toxin in the treatment of spasmodic torticollis
C Brefel-Courbon, M Simonetta-Moreau, C Moré, et al.
Clinical Neuropharmacology
|
June 8, 2001
Sleep attacks and antiparkinsonian drugs: a pilot prospective pharmacoepidemiologic study
J L Montastruc, C Brefel-Courbon, J M Senard, et al.
Revue Neurologique
|
October 8, 2014
An individual rehabilitation program: evaluation by Parkinsonian patients and their physiotherapists
F Ory Magne, N Fabre, C Gu, et al.
Fundamental & Clinical Pharmacology
|
December 29, 2000
Fluoxetine-induced pressor response in freely moving rats: a role for vasopressin and sympathetic tone
E Lazartigues, C Brefel-Courbon, H Bagheri, et al.
Fundamental & Clinical Pharmacology
|
August 26, 1998
Fluoxetine in orthostatic hypotension of Parkinson's disease: a clinical and experimental pilot study
J L Montastruc, M Pelat, P Verwaerde, et al.
European Journal of Pharmacology
|
December 16, 1998
Pressor and bradycardic effects of tacrine and other acetylcholinesterase inhibitors in the rat
E Lazartigues, J L Freslon, T Tellioglu, et al.
British Journal of Pharmacology
|
October 1, 1995
Central cardiovascular effects of acetylcholine in the conscious dog
C Brefel, E Lazartigues, M A Tran, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 62) with videos related to
Sort By:
Page
of 7
Archives Des Maladies Du Coeur Et Des Vaisseaux
|
September 16, 1999
[Reduction of the pressor effect of fluoxetine after V1A-vasopressin receptor blockade in the conscious rats]
E Lazartigues, S Costes, C Brefel-Courbon, et al.
Acta Neurologica Scandinavica
|
August 24, 2017
Cognitive complaint in early Parkinson's disease: A pilot study
J Dupouy, F Ory-Magne, C Mekies, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
May 17, 2007
Levodopa raises objective pain threshold in Parkinson's disease: a RIII reflex study
A Gerdelat-Mas, M Simonetta-Moreau, C Thalamas, et al.
Clinical Neuropharmacology
|
October 6, 2000
A pharmacoeconomic evaluation of botulinum toxin in the treatment of spasmodic torticollis
C Brefel-Courbon, M Simonetta-Moreau, C Moré, et al.
Clinical Neuropharmacology
|
June 8, 2001
Sleep attacks and antiparkinsonian drugs: a pilot prospective pharmacoepidemiologic study
J L Montastruc, C Brefel-Courbon, J M Senard, et al.
Revue Neurologique
|
October 8, 2014
An individual rehabilitation program: evaluation by Parkinsonian patients and their physiotherapists
F Ory Magne, N Fabre, C Gu, et al.
Fundamental & Clinical Pharmacology
|
December 29, 2000
Fluoxetine-induced pressor response in freely moving rats: a role for vasopressin and sympathetic tone
E Lazartigues, C Brefel-Courbon, H Bagheri, et al.
Fundamental & Clinical Pharmacology
|
August 26, 1998
Fluoxetine in orthostatic hypotension of Parkinson's disease: a clinical and experimental pilot study
J L Montastruc, M Pelat, P Verwaerde, et al.
European Journal of Pharmacology
|
December 16, 1998
Pressor and bradycardic effects of tacrine and other acetylcholinesterase inhibitors in the rat
E Lazartigues, J L Freslon, T Tellioglu, et al.
British Journal of Pharmacology
|
October 1, 1995
Central cardiovascular effects of acetylcholine in the conscious dog
C Brefel, E Lazartigues, M A Tran, et al.
Page
of 7